(Q42663773)

4 November 2017

title

Comparative behavioural profiles of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in the murine elevated plus-maze (English)

1 reference

4 November 2017

1 reference

Cao BJ

1

1 reference

4 November 2017

Rodgers RJ

series ordinal

2

1 reference

4 November 2017

publication date

1 August 1997

1 reference

4 November 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Neuropharmacology

1 reference

4 November 2017

volume

36

1 reference

4 November 2017

issue

8

1 reference

4 November 2017

page(s)

1089-1097

1 reference

Comparison of the anticonflict effect of buspirone and its major metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in rats.

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

Anxiolytic-like profile of p-MPPI, a novel 5HT1A receptor antagonist, in the murine elevated plus-maze.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

Influence of 5-HT1A receptor antagonism on plus-maze behaviour in mice. I. Pindolol enantiomers and pindobind 5-HT1A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

Different effects of intracerebral and systemic administration of buspirone in the forced swimming test: involvement of a metabolite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

Anxiolytic-like effects of yohimbine in the murine plus-maze: strain independence and evidence against alpha 2-adrenoceptor mediation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

Gepirone and 1-(2-pyrimidinyl)-piperazine-induced reduction of aversively evoked ultrasonic vocalisation in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

The effects of alpha 2-adrenoceptor antagonists on the inhibition of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced head shakes by 5-HT1A receptor agonists in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

Antagonist properties of 1-(2-pyrimidinyl)piperazine at presynaptic alpha 2-adrenoceptors in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

Alpha 2-adrenoceptor antagonist activity may account for the effects of buspirone in an anticonflict test in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ?fear?-motivated behaviour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

A review of the validity and variability of the elevated plus-maze as an animal model of anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

Autonomic and psychic effects of yohimbine hydrochloride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

The azapirone metabolite 1-(2-pyrimidinyl)piperazine depresses excitatory synaptic transmission in the hippocampus of the alert rat via 5-HT1A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

1-(2-Pyrimidinyl)-piperazine may alter the effects of the 5-HT1A agonists in the learned helplessness paradigm in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

Kinetics, brain uptake, and receptor binding of tandospirone and its metabolite 1-(2-pyrimidinyl)-piperazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

In vivo electrophysiological evidence for tonic activation by endogenous noradrenaline of alpha 2-adrenoceptors on 5-hydroxytryptamine terminals in the rat hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

Cerebral pharmacokinetics of ipsapirone in rats after different routes of administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

A re-evaluation of the role of alpha 2-adrenoceptors in the anxiogenic effects of yohimbine, using the selective antagonist delequamine in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

Anxiolytic-like effect of (S)-WAY 100135, a 5-HT1A receptor antagonist, in the murine elevated plus-maze test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

Discriminative stimulus properties of 8-OH-DPAT: relationship to affinity for 5HT1A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

Effect of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behaviour on the elevated X-maze

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

Novel benzodioxan derivative, 5-(3-[((2S)-1,4-benzodioxan-2- ylmethyl)amino]propoxy)-1,3-benzodioxole HCl (MKC-242), with a highly potent and selective agonist activity at rat central serotonin1A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900094-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0028-3908(97)00094-4

1 reference

4 November 2017

1 reference